HCP
PFE icon

Hamilton Capital Partners’s Pfizer PFE Stock Holding History

Hamilton Capital Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-13,220
Closed -$371K – 38
2026
Q1 		$371K Buy
+13,220
New +$352K 0.12% 22

Other funds holding PFE

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Hamilton Capital Partners's PFE Position: Q2 2026 in Review

Hamilton Capital Partners sold out of Pfizer (PFE) in Q2 2026, closing a stake of 13,220 shares — an estimated $371K sold.

Hamilton Capital Partners first reported a position in PFE in Q1 2026 and held it in 1 quarter. The position peaked at $371K in Q1 2026. 1,496 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Hamilton Capital Partners reported no remaining Pfizer position as of Q2 2026 after selling out during the quarter.
  • Hamilton Capital Partners sold 13,220 Pfizer shares in Q2 2026, an estimated $371K.
  • Hamilton Capital Partners first reported a position in Pfizer in Q1 2026 and held it in 1 quarter.
  • Hamilton Capital Partners's Pfizer position peaked at $371K in Q1 2026.
  • 1,496 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Hamilton Capital Partners's 13F filing for Q2 2026, filed 20 Jul 2026.